指南与共识区域麻醉与超声术前评估与围术期医学

外周神经阻滞用于初次髋膝关节置换术的ICAROS国际共识推荐

Peripheral nerve block anesthesia/analgesia for patients undergoing primary hip and knee arthroplasty: recommendations from the International Consensus on Anesthesia-Related Outcomes after Surgery (ICAROS) group based on a systematic review and meta-analysis of current literature.
指南 / 共识 · Reg Anesth Pain Med · 2021-08-25

ICAROS小组基于系统评价与荟萃分析制定国际专家共识,评估外周神经阻滞(PNB)在初次全髋/膝关节置换术(THA/TKA)中对主要并发症的影响。分析122项研究显示,PNB使用与认知功能障碍、呼吸衰竭、心脏并发症、手术部位感染、血栓栓塞及输血风险降低相关。共识推荐THA/TKA患者使用PNB以改善结局,证据级别中等,推荐强度强。

要点

  • PNB用于THA/TKA可降低认知功能障碍、呼吸衰竭等并发症风险。
  • 共识推荐THA/TKA患者使用PNB,除非存在禁忌证。
  • 需确保操作者技能与临床地点资源相匹配。

核心结论

  • 基于当前证据,共识小组推荐THA/TKA患者使用PNB以改善结局。

研究设计与样本

  • 系统评价与荟萃分析,纳入随机对照和观察性研究,评估PNB对主要并发症的影响。
  • 检索Medline、PubMed、Embase和Cochrane Library等数据库,时间从1946年至2020年8月4日。
  • 采用GRADE方法评估证据质量和制定推荐。
  • 共分析122项研究。

主要发现

  • PNB使用(与非使用相比)与THA/TKA后认知功能障碍风险降低相关(THA OR 0.30,95%CI 0.17-0.53;TKA OR 0.52,95%CI 0.34-0.80)。
  • PNB使用与呼吸衰竭风险降低相关(THA OR 0.36,95%CI 0.17-0.74;TKA OR 0.37,95%CI 0.18-0.75)。
  • PNB使用与心脏并发症风险降低相关(THA OR 0.84,95%CI 0.76-0.93;TKA OR 0.83,95%CI 0.79-0.86)。
  • PNB使用与手术部位感染风险降低相关(THA OR 0.55,95%CI 0.47-0.64;TKA OR 0.86,95%CI 0.80-0.91)。
  • PNB使用与血栓栓塞风险降低相关(THA OR 0.74,95%CI 0.58-0.96;TKA OR 0.90,95%CI 0.84-0.96),并与输血风险降低相关(THA OR 0.84,95%CI 0.83-0.86;TKA OR 0.91,95%CI 0.90-0.92)。

关键数值与推荐

  • 推荐THA/TKA患者使用PNB,除非存在禁忌证。
  • 需确保操作者技能与临床地点资源相匹配。
  • 证据级别:中等;推荐强度:强。

临床怎么用

  • 对于无禁忌证的THA/TKA患者,应考虑使用PNB以降低认知功能障碍、呼吸衰竭、心脏并发症、手术部位感染、血栓栓塞和输血风险。
  • 实施PNB前需评估操作者技能和临床地点资源是否匹配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence-based international expert consensus regarding the impact of peripheral nerve block (PNB) use in total hip/knee arthroplasty surgery. METHODS: A systematic review and meta-analysis: randomized controlled and observational studies investigating the impact of PNB utilization on major complications, including mortality, cardiac, pulmonary, gastrointestinal, renal, thromboembolic, neurologic, infectious, and bleeding complications.Medline, PubMed, Embase, and Cochrane Library including Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, were queried from 1946 to August 4, 2020.The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess evidence quality and for the development of recommendations. RESULTS: Analysis of 122 studies revealed that PNB use (compared with no use) was associated with lower ORs for (OR with 95% CIs) for numerous complications (total hip and knee arthroplasties (THA/TKA), respectively): cognitive dysfunction (OR 0.30, 95% CI 0.17 to 0.53/OR 0.52, 95% CI 0.34 to 0.80), respiratory failure (OR 0.36, 95% CI 0.17 to 0.74/OR 0.37, 95% CI 0.18 to 0.75), cardiac complications (OR 0.84, 95% CI 0.76 to 0.93/OR 0.83, 95% CI 0.79 to 0.86), surgical site infections (OR 0.55 95% CI 0.47 to 0.64/OR 0.86 95% CI 0.80 to 0.91), thromboembolism (OR 0.74, 95% CI 0.58 to 0.96/OR 0.90, 95% CI 0.84 to 0.96) and blood transfusion (OR 0.84, 95% CI 0.83 to 0.86/OR 0.91, 95% CI 0.90 to 0.92). CONCLUSIONS: Based on the current body of evidence, the consensus group recommends PNB use in THA/TKA for improved outcomes. RECOMMENDATION: PNB use is recommended for patients undergoing THA and TKA except when contraindications preclude their use. Furthermore, the alignment of provider skills and practice location resources needs to be ensured. Evidence level: moderate; recommendation: strong.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Memtsoudis SG, Cozowicz C, Bekeris J, et al. Peripheral nerve block anesthesia/analgesia for patients undergoing primary hip and knee arthroplasty: recommendations from the International Consensus on Anesthesia-Related Outcomes after Surgery (ICAROS) group based on a systematic review and meta-analysis of current literature. Reg Anesth Pain Med. 2021. PMID: 34433647. doi:10.1136/rapm-2021-102750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。